Viking Global Investors LP Edwards Lifesciences Corp Transaction History

Viking Global Investors LP

  • $25.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020
SELL
$52.41 - $81.0 $8.31 Million - $12.8 Million
-158,573 Closed
0 $0
Q4 2019

Feb 13, 2020
SELL
$71.7 - $82.09 $3.27 Million - $3.74 Million
-45,575 Reduced 22.32%
158,573 $37 Million
Q3 2019

Nov 13, 2019
BUY
$61.55 - $75.43 $12.6 Million - $15.4 Million
204,148 New
204,148 $44.9 Million

Others Institutions Holding EW

# of Institutions
1,350
Shares Held
456M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email